University of Science and Technology of China
ORCID: 0000-0002-2079-996XPilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Driven by 7 papers. Top paper: “265O Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial”.
M. Gao, Y. Zhang, F. Shi, Y. Cheng, Z. Guo +14 more
Erlend Aakvaag, B. Abbott, Sara Abdelhameed, K. Abeling, Nils Julius Abicht +2912 more
G. Aad, Erlend Aakvaag, B. Abbott, Sara Abdelhameed, K. Abeling +2908 more
Erlend Aakvaag, B. Abbott, Sara Abdelhameed, K. Abeling, Nils Julius Abicht +2842 more
X. Zheng, J. Fine, Y. Li, W. Zhong, Fine, J. +1 more
Quanpeng Li, Yanwei Li, Daipeng Wu, T.B. Poston, Karen L. Mohlke +5 more
Weidong Jia, Huixia Li, W. Zhong, X. Zheng, Z. Zhou +7 more